Report Detail
Global High Potency API Contract Manufacturing Market Growth (Status and Outlook) 2022-2028
- RnM4489125 |
- 31 August, 2022 |
- Global |
- 100 Pages |
- LPI(LP Information) |
- Service & Software
Highly potent APIs are compounds that elicit a biological response at a very low dose. Active pharmaceutical ingredient (API) contract manufacturing indicates to the overall development of the pharma drugs with the help of contract manufacturing by outsourcing other companies.
The global market for High Potency API Contract Manufacturing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC High Potency API Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States High Potency API Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe High Potency API Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China High Potency API Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key High Potency API Contract Manufacturing players cover Piramal Pharma Solutions, Lonza, Catalent, Inc., VxP Pharma, Inc. and Pfizer CentreOne, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global High Potency API Contract Manufacturing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global High Potency API Contract Manufacturing market, with both quantitative and qualitative data, to help readers understand how the High Potency API Contract Manufacturing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the High Potency API Contract Manufacturing market and forecasts the market size by Type (Injectable, Oral Solids and Creams), by Application (Synthetic and Biotech.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Injectable
Oral Solids
Creams
Others
Segmentation by application
Synthetic
Biotech
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Piramal Pharma Solutions
Lonza
Catalent, Inc.
VxP Pharma, Inc.
Pfizer CentreOne
Gentec Pharmaceutical Group
AbbVie
Aurigene Pharmaceutical Services Ltd.
CordenPharma International
Curia Global, Inc.
Chapter Introduction
Chapter 1: Scope of High Potency API Contract Manufacturing, Research Methodology, etc.
Chapter 2: Executive Summary, global High Potency API Contract Manufacturing market size and CAGR, High Potency API Contract Manufacturing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: High Potency API Contract Manufacturing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global High Potency API Contract Manufacturing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global High Potency API Contract Manufacturing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Piramal Pharma Solutions, Lonza, Catalent, Inc., VxP Pharma, Inc., Pfizer CentreOne, Gentec Pharmaceutical Group, AbbVie, Aurigene Pharmaceutical Services Ltd. and CordenPharma International, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global High Potency API Contract Manufacturing Market Size 2017-2028
- 2.1.2 High Potency API Contract Manufacturing Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 High Potency API Contract Manufacturing Segment by Type
- 2.2.1 Injectable
- 2.2.2 Oral Solids
- 2.2.3 Creams
- 2.2.4 Others
- 2.3 High Potency API Contract Manufacturing Market Size by Type
- 2.3.1 High Potency API Contract Manufacturing Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global High Potency API Contract Manufacturing Market Size Market Share by Type (2017-2022)
- 2.4 High Potency API Contract Manufacturing Segment by Application
- 2.4.1 Synthetic
- 2.4.2 Biotech
- 2.5 High Potency API Contract Manufacturing Market Size by Application
- 2.5.1 High Potency API Contract Manufacturing Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global High Potency API Contract Manufacturing Market Size Market Share by Application (2017-2022)
3 High Potency API Contract Manufacturing Market Size by Player
- 3.1 High Potency API Contract Manufacturing Market Size Market Share by Players
- 3.1.1 Global High Potency API Contract Manufacturing Revenue by Players (2020-2022)
- 3.1.2 Global High Potency API Contract Manufacturing Revenue Market Share by Players (2020-2022)
- 3.2 Global High Potency API Contract Manufacturing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 High Potency API Contract Manufacturing by Regions
- 4.1 High Potency API Contract Manufacturing Market Size by Regions (2017-2022)
- 4.2 Americas High Potency API Contract Manufacturing Market Size Growth (2017-2022)
- 4.3 APAC High Potency API Contract Manufacturing Market Size Growth (2017-2022)
- 4.4 Europe High Potency API Contract Manufacturing Market Size Growth (2017-2022)
- 4.5 Middle East & Africa High Potency API Contract Manufacturing Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas High Potency API Contract Manufacturing Market Size by Country (2017-2022)
- 5.2 Americas High Potency API Contract Manufacturing Market Size by Type (2017-2022)
- 5.3 Americas High Potency API Contract Manufacturing Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC High Potency API Contract Manufacturing Market Size by Region (2017-2022)
- 6.2 APAC High Potency API Contract Manufacturing Market Size by Type (2017-2022)
- 6.3 APAC High Potency API Contract Manufacturing Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe High Potency API Contract Manufacturing by Country (2017-2022)
- 7.2 Europe High Potency API Contract Manufacturing Market Size by Type (2017-2022)
- 7.3 Europe High Potency API Contract Manufacturing Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa High Potency API Contract Manufacturing by Region (2017-2022)
- 8.2 Middle East & Africa High Potency API Contract Manufacturing Market Size by Type (2017-2022)
- 8.3 Middle East & Africa High Potency API Contract Manufacturing Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global High Potency API Contract Manufacturing Market Forecast
- 10.1 Global High Potency API Contract Manufacturing Forecast by Regions (2023-2028)
- 10.1.1 Global High Potency API Contract Manufacturing Forecast by Regions (2023-2028)
- 10.1.2 Americas High Potency API Contract Manufacturing Forecast
- 10.1.3 APAC High Potency API Contract Manufacturing Forecast
- 10.1.4 Europe High Potency API Contract Manufacturing Forecast
- 10.1.5 Middle East & Africa High Potency API Contract Manufacturing Forecast
- 10.2 Americas High Potency API Contract Manufacturing Forecast by Country (2023-2028)
- 10.2.1 United States High Potency API Contract Manufacturing Market Forecast
- 10.2.2 Canada High Potency API Contract Manufacturing Market Forecast
- 10.2.3 Mexico High Potency API Contract Manufacturing Market Forecast
- 10.2.4 Brazil High Potency API Contract Manufacturing Market Forecast
- 10.3 APAC High Potency API Contract Manufacturing Forecast by Region (2023-2028)
- 10.3.1 China High Potency API Contract Manufacturing Market Forecast
- 10.3.2 Japan High Potency API Contract Manufacturing Market Forecast
- 10.3.3 Korea High Potency API Contract Manufacturing Market Forecast
- 10.3.4 Southeast Asia High Potency API Contract Manufacturing Market Forecast
- 10.3.5 India High Potency API Contract Manufacturing Market Forecast
- 10.3.6 Australia High Potency API Contract Manufacturing Market Forecast
- 10.4 Europe High Potency API Contract Manufacturing Forecast by Country (2023-2028)
- 10.4.1 Germany High Potency API Contract Manufacturing Market Forecast
- 10.4.2 France High Potency API Contract Manufacturing Market Forecast
- 10.4.3 UK High Potency API Contract Manufacturing Market Forecast
- 10.4.4 Italy High Potency API Contract Manufacturing Market Forecast
- 10.4.5 Russia High Potency API Contract Manufacturing Market Forecast
- 10.5 Middle East & Africa High Potency API Contract Manufacturing Forecast by Region (2023-2028)
- 10.5.1 Egypt High Potency API Contract Manufacturing Market Forecast
- 10.5.2 South Africa High Potency API Contract Manufacturing Market Forecast
- 10.5.3 Israel High Potency API Contract Manufacturing Market Forecast
- 10.5.4 Turkey High Potency API Contract Manufacturing Market Forecast
- 10.5.5 GCC Countries High Potency API Contract Manufacturing Market Forecast
- 10.6 Global High Potency API Contract Manufacturing Forecast by Type (2023-2028)
- 10.7 Global High Potency API Contract Manufacturing Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Piramal Pharma Solutions
- 11.1.1 Piramal Pharma Solutions Company Information
- 11.1.2 Piramal Pharma Solutions High Potency API Contract Manufacturing Product Offered
- 11.1.3 Piramal Pharma Solutions High Potency API Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Piramal Pharma Solutions Main Business Overview
- 11.1.5 Piramal Pharma Solutions Latest Developments
- 11.2 Lonza
- 11.2.1 Lonza Company Information
- 11.2.2 Lonza High Potency API Contract Manufacturing Product Offered
- 11.2.3 Lonza High Potency API Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Lonza Main Business Overview
- 11.2.5 Lonza Latest Developments
- 11.3 Catalent, Inc.
- 11.3.1 Catalent, Inc. Company Information
- 11.3.2 Catalent, Inc. High Potency API Contract Manufacturing Product Offered
- 11.3.3 Catalent, Inc. High Potency API Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Catalent, Inc. Main Business Overview
- 11.3.5 Catalent, Inc. Latest Developments
- 11.4 VxP Pharma, Inc.
- 11.4.1 VxP Pharma, Inc. Company Information
- 11.4.2 VxP Pharma, Inc. High Potency API Contract Manufacturing Product Offered
- 11.4.3 VxP Pharma, Inc. High Potency API Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 VxP Pharma, Inc. Main Business Overview
- 11.4.5 VxP Pharma, Inc. Latest Developments
- 11.5 Pfizer CentreOne
- 11.5.1 Pfizer CentreOne Company Information
- 11.5.2 Pfizer CentreOne High Potency API Contract Manufacturing Product Offered
- 11.5.3 Pfizer CentreOne High Potency API Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Pfizer CentreOne Main Business Overview
- 11.5.5 Pfizer CentreOne Latest Developments
- 11.6 Gentec Pharmaceutical Group
- 11.6.1 Gentec Pharmaceutical Group Company Information
- 11.6.2 Gentec Pharmaceutical Group High Potency API Contract Manufacturing Product Offered
- 11.6.3 Gentec Pharmaceutical Group High Potency API Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Gentec Pharmaceutical Group Main Business Overview
- 11.6.5 Gentec Pharmaceutical Group Latest Developments
- 11.7 AbbVie
- 11.7.1 AbbVie Company Information
- 11.7.2 AbbVie High Potency API Contract Manufacturing Product Offered
- 11.7.3 AbbVie High Potency API Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 AbbVie Main Business Overview
- 11.7.5 AbbVie Latest Developments
- 11.8 Aurigene Pharmaceutical Services Ltd.
- 11.8.1 Aurigene Pharmaceutical Services Ltd. Company Information
- 11.8.2 Aurigene Pharmaceutical Services Ltd. High Potency API Contract Manufacturing Product Offered
- 11.8.3 Aurigene Pharmaceutical Services Ltd. High Potency API Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Aurigene Pharmaceutical Services Ltd. Main Business Overview
- 11.8.5 Aurigene Pharmaceutical Services Ltd. Latest Developments
- 11.9 CordenPharma International
- 11.9.1 CordenPharma International Company Information
- 11.9.2 CordenPharma International High Potency API Contract Manufacturing Product Offered
- 11.9.3 CordenPharma International High Potency API Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 CordenPharma International Main Business Overview
- 11.9.5 CordenPharma International Latest Developments
- 11.10 Curia Global, Inc.
- 11.10.1 Curia Global, Inc. Company Information
- 11.10.2 Curia Global, Inc. High Potency API Contract Manufacturing Product Offered
- 11.10.3 Curia Global, Inc. High Potency API Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Curia Global, Inc. Main Business Overview
- 11.10.5 Curia Global, Inc. Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on High Potency API Contract Manufacturing. Industry analysis & Market Report on High Potency API Contract Manufacturing is a syndicated market report, published as Global High Potency API Contract Manufacturing Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of High Potency API Contract Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
